474 Results (Page 19 of 19)
UAE Markets Research Reports
UAE Ear Infection Therapeutics Market Analysis
UAE Ear Infection Therapeutics Market valued at $59 Mn in 2022, is projected to reach $95 Mn by 2030 with a 6.2% CAGR. The rising incidence of ear infections, particularly among children, significantly drives the growth of the ear infection therapeutics market, acting as a catalyst for extensive research, development, and the availability of treatments to address this widespread medical condition. Notable companies in this sector encompass Pfizer, GlaxoSmithKline, Johnson & Johnson, Merck & Co., Eli Lilly, Novartis, Teva Pharmaceutical, Mylan, Hikma Pharmaceuticals, and Sun Pharmaceutical.
UAE Compression Therapy Market Analysis
UAE Compression Therapy Market was valued at $19 Mn in 2022 and is estimated to reach $32 Mn in 2030, exhibiting a CAGR of 6.6% during the forecast period. The increasing occurrence of venous conditions such as leg ulcers, deep vein thrombosis, lymphedema, varicose veins, and blood clots is a major factor contributing to the expansion of the compression therapy market. Leading companies in this sector include Medi France, Sigvaris, Juzo, Bauerfeind, Jobst, Lympha Press, FLA Orthopedics, Al-Johaifa Medical, Nahdi Pharmacy, and AstraZeneca.
UAE CT Scan Market Analysis
UAE CT Scan Market was valued at $23.05 Mn in 2023 and is predicted to grow at a CAGR of 8.87% from 2023 to 2030, to $41.79 Mn by 2030. The key drivers of this industry include the rising prevalence of chronic diseases, the growing population, and government investments in healthcare. The industry is primarily dominated by GE HealthCare, Siemens Healthineers, Canon Medical Systems, and NeuroLogica Corp. among others.
UAE Cough Hypersensitivity Syndrome Therapeutics Market Analysis
The UAE Cough Hypersensitivity Syndrome Therapeutics Market was valued at $41 Mn in 2022 and is predicted to grow at a CAGR of 6.9% from 2023 to 2030, to $69 Mn by 2030. The key drivers of this industry include the rising prevalence of Cough Hypersensitivity Syndrome, supportive government initiatives, and the development of novel therapeutics. The industry is primarily dominated by players such as Sanofi, Pfizer, Akorn, Novartis, Johnson & Johnson, and GSK among others.
UAE Bio-Implant Market Analysis
The UAE Bio-implant Market was valued at $325 Mn in 2023 and is predicted to grow at a CAGR of 6.9% from 2023 to 2030, to $518.5 Mn by 2030. The UAE Bio-implant Market is growing due to the Growing Aging Population, Government Initiatives and Healthcare Infrastructure Development, and Rising Chronic Disease Prevalence. The market is primarily dominated by players such as ProvenMed, Global Med Hub FZ LLC, Sinterex, ThermoMind, Zimmer Biomet, Boston Scientific Corporation, Otto Bock Holding GmbH & Co. KG, and Medtronic plc.
UAE Herbal Supplements Market Report
The UAE Herbal Supplements Market was valued at $26.30 Mn in 2023 and is predicted to grow at a CAGR of 7.2% from 2023 to 2030, to $42.79 Mn by 2030. The key drivers of this industry include health and wellness trends, cultural influence, and government initiatives. The industry is primarily dominated by players such as Himalaya Wellness, Dabur, Herbalife Nutrition, and Healwell Pharma among others.
UAE Brugada Syndrome Market Analysis
The UAE Brugada Syndrome Market was valued at $6 Mn in 2023 and is predicted to grow at a CAGR of 8.8% from 2023 to 2030, to $10.8 Mn by 2030. The key drivers of the market include growing prevalence of cardiovascular diseases, aging population, and advancements in genetic testing. The prominent players of the UAE Brugada Syndrome Market are Julphar, Neopharma, Novartis, Boehringer Ingelheim, and Gulf Scientific Corporation, among others.
UAE Clinical Nutrition for Chronic Kidney Diseases Market Analysis
UAE Clinical Nutrition for Chronic Kidney Diseases Market was valued at $7.80 Mn in 2023 and is predicted to grow at a CAGR of 7.03% from 2023 to 2030, to $12.60 Mn by 2030. The key drivers of this industry include the rising prevalence of CKD, growing awareness and diagnosis, advancements in medical research, and the aging population. The industry is primarily dominated by Abbott Nutrition, Pfizer Inc., Bayer AG, and Nestlé Health Science among others.
UAE Brain Cancer Therapeutics Market
UAE Brain Cancer Therapeutics Market valued at $12 Mn in 2022, projected to reach $28 Mn by 2030 with a 11.6% CAGR. The market for brain cancer therapeutics is expected to be driven by the anticipated rise in the incidence of brain cancer, especially glioblastoma multiforme, which would raise the demand for therapeutics. Among the prominent players in the pharmaceutical sector are Roche, Merck, Novartis, Bristol Myers Squibb, Eli Lilly, Pfizer, AstraZeneca, Teva Pharmaceutical Industries, Sanofi, and Ipsen.
UAE Dental Endodontics Market Analysis
UAE Dental Endodontics Market was valued at $8.80 Mn in 2023 and is predicted to grow at a CAGR of 5.3% from 2023 to 2030, to $12.60 Mn by 2030. The key drivers of this industry include growing demand, rising prevalence of dental problems, and technological advancements. The industry is primarily dominated by Coltene, Dentsply Sirona, FKG Dentaire, and Ultradent Products among others.
UAE Clinical Nutrition Market Analysis
The UAE Clinical Nutrition Market was valued at $153.3 Mn in 2023 and is projected to grow at a CAGR of 6.34% from 2023 to 2023, to $235.8 Mn by 2030. The key drivers of this industry are increasing prevalence of chronic diseases and metabolic disorders, aging population, increasing awareness of the importance of nutrition for health, product innovations and technological advancements, government initiatives and rising healthcare expenditure, rising incidence of malnutrition especially in paediatric patients which has contributed to market growth. The industry is primarily dominated by players such as BASF, B Braun, Abbott Nutrition, Pfizer Inc, Bayer AG, Nestle, Baxter International Inc., Otsuka Holdings Co., Ltd among others.
UAE Blood Disorder Therapeutics Market
UAE Blood Disorder Therapeutics Market valued at $67 Mn in 2022, projected to reach $129 Mn by 2030 with a 8.5% CAGR. The UAE's political and economic stability, regional healthcare initiatives, aging populations, rising lifestyle trends that are contributing to an increase in chronic diseases, and improvements in diagnostic technologies that are providing more targeted and effective treatments are the main factors driving the market's growth. The UAE Blood Disorder Therapeutics Market encompasses various players across different segments, including Pfizer, Novartis, Roche, Bayer, Takeda Pharmaceuticals, Gilead, Sanofi, Neopharma, Julphar, Sun Pharma etc, among various others.
UAE Digital Biomarkers Market Analysis
UAE Digital Biomarkers Market was valued at $14.50 Mn in 2023 and is predicted to grow at a CAGR of 23.3% from 2023 to 2030, to $62.82 Mn by 2030. The key drivers of this industry include the rising prevalence of chronic diseases, government initiatives, increased tech adoption, and focus on preventative care. The industry is primarily dominated by ActiGraph LLC, AliveCor Inc., Koneksa, and Altoida Inc. among others.
UAE Congestive Heart Failure Therapeutics Market Analysis
The UAE Congestive Heart Failure Therapeutics Market is anticipated to experience a growth from $52 Mn in 2022 to $87 Mn by 2030, with a CAGR of 6.8% during the forecast period of 2022-2030. The market is growing due to the presence of increasing government initiatives that actively encourage research and collaboration, the rising prevalence of cardiovascular disease, and a favorable environment conducive to advancements in therapeutics. The UAE Congestive Heart Failure Therapeutics Market encompasses various key players across different therapeutic segments, including Johnson & Johnson, Merck, Novartis, Pfizer, Sanofi, AstraZeneca, Julphar, RAK Pharma, Pharmed, Cipla, etc, among various others.
UAE Cardiac Resynchronization Therapy Market
UAE Cardiac Resynchronization Therapy Market valued at $24 Mn in 2022, projected to reach $38 Mn by 2030 with a 6% CAGR. The increasing worldwide incidence of heart failure, propelled by aging demographics and cardiovascular diseases linked to lifestyle, emerges as a significant factor fuelling the growth of the Cardiac Resynchronization Therapy (CRT) market. Presently, prominent players in this market encompass Abbott, Boston Scientific, Medtronic, Siemens Healthineers, Johnson & Johnson, Biotronik, LivaNova, MicroPort, Sorin Group, and St. Jude Medical.
UAE Physiotherapy Equipment Market Analysis
The UAE Physiotherapy Equipment Market was valued at $104.50 Mn in 2023 and is predicted to grow at a CAGR of 8.2% from 2023 to 2030, to $181.43 Mn by 2030. The key drivers of this industry include the rising prevalence of chronic diseases, expanding geriatric population, and advancements in technology. The key players in the industry are HMS Medical Systems, Medicaregt, EMS Physio Ltd., and Bionex Medical Equipment among others.
UAE Dental Consumables Market Analysis
The UAE Dental Consumables Market was valued at $169 Mn in 2023 and is projected to grow at a CAGR of 9.0% from 2023 to 2023, to $308.9 Mn by 2030. The key drivers of this industry growing dental care needs, technological advancements, expanding dental infrastructure, increasing disposable incomes, public health initiatives, dental tourism, rising consumption of sugary and starchy foods, rise in unhealthy eating habits due to rising urbanization, changing living standards. The industry is primarily dominated by players such as Dubai Medical Equipment LLC, Advanced Healthcare Medical Equipment LLC, Dentsply Sirona, Danaher, Align Technology, 3M, among others.
UAE Cardiac Arrhythmia Therapeutics Market Analysis
UAE Cardiac Arrhythmia Therapeutics Market valued at $36 Mn in 2022, projected to reach $61 Mn by 2030 with a 6.8% CAGR. The key drivers of this industry include the increasing prevalence of cardiac diseases, technological advancements, and growing public health programs. The industry is primarily dominated by players such as Abbott, Medtronic, Biotronik, GE, Siemens, Philips, Johnson & Johnson, and Boston Scientific among others.
UAE Biosensors Market Analysis
The UAE Biosensors Market was valued at $144.5 Mn in 2023 and is predicted to grow at a CAGR of 9% from 2023 to 2030, to $264.1 Mn by 2030. The key drivers of the market include increasing burden of chronic diseases, emphasis on preventative care, and aging population. The prominent players of the UAE Biosensors Market are Al Jawahir Medical Supplies, AboneMed Medical Equipment LLC, Al-Ewan Medical Company, Almafsal Medical Company, and Al Razi Medical Company, among others.
UAE Medical Digital Imaging System Market Analysis
The UAE Medical Digital Imaging System Market was valued at $152.5 Mn in 2023 and is predicted to grow at a CAGR of 9.2% from 2023 to 2030, to $282.38 Mn by 2030. The key drivers of this industry include government initiatives, infrastructure development, and rising chronic diseases. The industry is primarily dominated by players such as Siemens Healthineers, GE Healthcare, Philips Healthcare, and Canon Medical Systems among others.
UAE Hemodialysis Vascular Grafts Market Analysis
UAE Hemodialysis Vascular Grafts Market was valued at $1.05 Bn in 2023 and is predicted to grow at a CAGR of 6.1% from 2023 to 2030, to $1.59 Bn by 2030. The key drivers of this industry include the rising prevalence of end-stage renal disease, the growing geriatric population, and government investment in healthcare. The industry is primarily dominated by W. L. Gore, C. R. Bard, Vascudyne, and LeMaitre among others.
UAE Hospital Market Analysis
The UAE Hospital Market was valued at $27.50 Bn in 2023 and is predicted to grow at a CAGR of 8.6% from 2023 to 2030, to $48.99 Bn by 2030. The key drivers of this industry prevalence of chronic disease, privatization of healthcare, and preventive care. The key players in the industry are Mediclinic Middle East, Aster DM Healthcare, Al Zahra Hospital, and Thumbay Group among others.
UAE Hemodialysis Equipment Market Analysis
The UAE Hemodialysis Equipment Market was valued at $70.6 Mn in 2023 and is projected to grow at a CAGR of 8.6% from 2023 to 2023, to $125.8 Mn by 2030. The key drivers of this industry are increasing incidence of chronic kidney disease (CKD) and end-stage renal disease (ESRD), availability of advanced dialysis machines and consumables, government initiatives to improve dialysis accessibility, growing adoption of home haemodialysis, expansion of dialysis service providers which has contributed to market growth. The industry is primarily dominated by players such as Baxter, B. Braun SE, Fresenius Medical Care AG, Medtronic, Asahi Kasei Medical Co., Ltd, Nipro Corp, DaVita, Quanta Dialysis Technologies among others.
UAE Graft-versus-Host Disease (GvHD) Therapeutics Market Analysis
The UAE GvHD Therapeutics Market was valued at $12.5 Mn in 2023 and is predicted to grow at a CAGR of 9.1% from 2023 to 2030, to $23 Mn by 2030. The drivers responsible for growth are the increasing prevalence of blood diseases, specialized treatments, and competitive landscapes. The key competitors are JCR, Takeda, Janssen, MaaT, XeniKos, Medac, Incyte, Mesoblast and others.